Dose Smarter

Deliver AI-powered personalized dosing recommendations for your patients.

spiral image dots

Why Personalized Dosing?

Unlike conventional dosing approaches which assume each patient is an average drug responder, the Dosis platform leverages artificial intelligence and control algorithms to determine a patient’s unique response to a medication and deliver optimal dose recommendations.

Increase Dose Efficiency

Use less drug to achieve equivalent or improved patient outcomes. An increase in dose efficiency means lowered drug exposure for patients and lowered costs for clinics.

Decrease Risk of Adverse Events

Decrease the likelihood of serious adverse events by decreasing patient exposure to drugs. Higher doses are associated with a higher likelihood of adverse events.

The Dosis Platform

Dosis is a cloud-based clinical decision support platform that uses artificial intelligence and control algorithms to personalize drug dosing.

Precise Recommendations

Generates personalized recommendations to keep patients within a specified therapeutic range

Increased Dose Efficiency

Empowers clinicians to use dramatically less medication to achieve the same or better patient outcomes

Proven Track Record

Used in clinics across the United States, and backed by years of peer-reviewed research

Strategic Anemia Advisor

Used in over 30 million treatments, SAA personalizes drug dosing for erythropoiesis-stimulating agents (ESAs), a class of drugs used to treat dialysis patients with chronic anemia.

Our Clinics See Results

Clinics that use SAA achieve equivalent or improved hemoglobin outcomes while using dramatically less drug, resulting in reduced patient drug exposure and reduced drug cost.

Learn More


We earn when you save. Our pricing model is built on aligned incentives, and we only charge a portion of the savings you realize.

No cost upfront
No cost upfront
Pay a percentage of your savings
Pay a percentage of your savings
request a demo

Recent Dosis News

October 2022

Dosis News

Dosis Demonstrates 40% Reduction in Epoetin Beta Utilization with Maintained Hemoglobin Levels

Dosis, a market leader in artificial intelligence-powered precision dosing, announced today the publication of two ...

Read Now

October 2022

Dosis News

2022 Fierce Healthcare Innovation Awards Finalists

Clinical Information Management Finalist Strategic Anemia Advisor Dosis Inc. ...

May 2022

Dosis News

Dosis Announces Nationwide Precision Dosing Implementation with DaVita

Dosis, a market leader in artificial intelligence-powered precision dosing, announced today the implementation of its ...

See all news & insights